Satellos Bioscience

Developer of small molecule drugs for rare diseases

placeToronto, Ontario, Canada calendar_todayFounded 2012 groups3 employees language satellos.com

Registered entities

Innovation

4 patent families — focus: Chemistry & metallurgy, Human necessities; filing pace accelerating. Cited 8 times.

YearFilings
20191
20211
20252
20261

Investor mix

3 investors on record; lead investors include Parent Project Muscular Dystrophy.

Investor typeCountShare
Venture capital267%
Other / undisclosed133%
Coming soon